Latest Breaking News On - World congress on parkinson disease - Page 1 : vimarsana.com

Mitsubishi Tanabe Pharma America Announces Presentations at XXVIII World Congress on Parkinson s Disease and Related Disorders

Mitsubishi Tanabe Pharma America Announces Presentations at XXVIII World Congress on Parkinson s Disease and Related Disorders
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesStuarth isaacsonGustavoa suarez zambranoBoca ratonJoaquimj ferreiraMovement disorders centerWorld congress on parkinson diseaseMitsubishi chemical groupUniversity of lisbonPrnewswire mitsubishi tanabe pharma america incNeuroderm ltdMitsubishi tanabe pharma america incInternational association of parkinsonismMitsubishi tanabe pharma corporationTanabe pharma americaInternational association

Kyowa Kirin Presents New Findings from Real-World Study in Parkinson s Disease at the 2023 IAPRD Conference

/PRNewswire/ Kyowa Kirin, Inc., an affiliate of Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151), a global specialty pharmaceutical company, will share.

United statesAsia pacificInternational association of parkinsonismWorld congress on parkinson diseaseWorld congressPrnewswire kyowa kirin incMovement disordersKyowa kirin co ltdKyowa kirin incInternational associationRelated disordersKyowa kirinPsychotic behaviorCompulsive behaviorsPrescribing informationNorth america

GAIN THERAPEUTICS : REPORTS second QUARTER 2022 FINANCIAL RESULTS AND BUSINESS UPDATE - Form 8-K

GAIN THERAPEUTICS, INC. REPORTS second QUARTER 2022 FINANCIAL RESULTS AND BUSINESS UPDATE Presented Additional Supportive Preclinical Data for. | August 8, 2022

Glucocerebrosidase gcaseStacey jurchinsonEric richmanEuropean union horizonMovement society disorderGain therapeutics incExchange commission onWorld congress on parkinson diseaseZentalis pharmaceuticalsCompany annual report on formSilverstein foundation for parkinsonInternational parkinsonMichaelj fox foundation for parkinson researchAdditional supportive preclinical dataLead candidateFurther validating therapeutic potential

Gain Therapeutics, Inc Reports Second Quarter 2022 Financial Results and Business Update

Gain Therapeutics, Inc Reports Second Quarter 2022 Financial Results and Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Glucocerebrosidase gcaseStacey jurchisonEric richmanEuropean union horizonMovement society disorderGain therapeutics incExchange commission onWorld congress on parkinson diseaseZentalis pharmaceuticalsCompany annual report on formSilverstein foundation for parkinsonInternational parkinsonMichaelj fox foundation for parkinson researchWall streetChief executive officerRelated disorders

Gain Therapeutics Presents Positive Preclinical Data on its Small Molecule Lead Compound in GBA1 Parkinson s Disease at XXVII IAPRD World Congress

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Czech republicEric richmanEuropean union horizonSilverstein foundation for parkinsonGain therapeutics incWorld congress on parkinson diseaseMichaelj fox foundation for parkinson researchRelated disordersChief executive officerManolo bellottoChief strategy officerGlucocerebrosidase shows evidencePharmacological efficacyGain therapeuticsSilverstein foundationMedia contacts